Powerbrands drive GSK Consumer Healthcare

26 July 2019 - Deborah Wilkes

Premium

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 4% at constant exchange rates in the second quarter of 2019. The company said growth had been driven primarily by the performance of its powerbrands, including Sensodyne with sales growth of 7%.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: